MAB439
antibody from R&D Systems
Targeting: CCL22
A-152E5.1, ABCD-1, DC/B-CK, MDC, MGC34554, SCYA22, STCP-1
Antibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB439 - Provider product page
- Provider
- R&D Systems
- Product name
- Mouse CCL22/MDC Antibody
- Antibody type
- Monoclonal
- Description
- Protein A or G purified from hybridoma culture supernatant. Detects mouse CCL22/MDC in direct ELISAs and Western blots. Shows 12% cross-reactivity with recombinant human (rh) CCL22 and recombinant mouse (rm) MIP-3 alpha , 25% cross-reactivity with rmCTACK, 6% cross-reactivity with rhBLC/BCA-1, and no cross-reactivity with rcrMIP-1 alpha , rhMIP-1 alpha , rmMIP-1 alpha , rcrMIP-1 beta , rmMIP-1 beta , rhMIP-1 beta rhPARC, rcrRANTES, rhRANTES, rmRANTES, rhTARC, or rmTARC,
- Reactivity
- Mouse
- Host
- Rat
- Conjugate
- Unconjugated
- Antigen sequence
O88430
- Isotype
- IgG
- Antibody clone number
- 158113
- Vial size
- 500 ug
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Submitted references CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling.
Kearley J, Robinson DS, Lloyd CM
The Journal of allergy and clinical immunology 2008 Sep;122(3):617-24.e6
The Journal of allergy and clinical immunology 2008 Sep;122(3):617-24.e6
No comments: Submit comment
No validations: Submit validation data